dc.contributorCenter for Genetic Engineering and Biotechnology (CIGB)
dc.contributorCIGB
dc.contributorPontifícia Universidade Católica do Paraná (PUCPR)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorInstituto de Ciencia Animal (ICA)
dc.contributorNational Laboratory for Parasitology
dc.contributorCICESE
dc.contributorInstitut Pasteur de Montevideo
dc.contributorInstituto de Investigaciones Biológicas Clemente Estable (IIBCE)
dc.date.accessioned2020-12-12T02:13:06Z
dc.date.accessioned2022-12-19T21:07:19Z
dc.date.available2020-12-12T02:13:06Z
dc.date.available2022-12-19T21:07:19Z
dc.date.created2020-12-12T02:13:06Z
dc.date.issued2020-06-01
dc.identifierPathogens, v. 9, n. 6, p. 1-26, 2020.
dc.identifier2076-0817
dc.identifierhttp://hdl.handle.net/11449/200678
dc.identifier10.3390/pathogens9060513
dc.identifier2-s2.0-85087288275
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5381312
dc.description.abstractA synthetic 20 amino acid peptide of the ribosomal protein P0 from ticks, when conjugated to keyhole limpet hemocyanin from Megathura crenulata and used as an immunogen against Rhipicephalus microplus and Rhipicephalus sanguineus s.l. species, has shown efficacies of around 90%. There is also experimental evidence of a high efficacy of this conjugate against Amblyomma mixtum and Ixodes ricinus species, which suggest that this antigen could be a good broad-spectrum anti-tick vaccine candidate. In this study, the P0 peptide (pP0) was chemically conjugated to Bm86 as a carrier protein. SDS-PAGE analysis of this conjugate demonstrated that it is highly heterogeneous in size, carrying from 1 to 18 molecules of pP0 per molecule of Bm86. Forty-nine out of the 54 lysine residues and the N-terminal end of Bm86 were found partially linked to pP0 by using LC-MS/MS analysis and the combination of four different softwares. Several post-translational modifications of Bm86 protein were also identified by mass spectrometry. High immunogenicity and efficacy were achieved when dogs and cattle were vaccinated with the pP0–Bm86 conjugate and challenged with R. sanguineus s.l. and R. microplus, respectively. These results encourage the development of this antigen with promising possibilities as an anti-tick vaccine.
dc.languageeng
dc.relationPathogens
dc.sourceScopus
dc.subjectAnti-tick vaccine
dc.subjectBm86
dc.subjectChemical conjugation
dc.subjectCross-linked peptides
dc.subjectP0
dc.subjectPeptide
dc.titleFunctional and mass spectrometric evaluation of an anti-tick antigen based on the P0 peptide conjugated to Bm86 protein
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución